$0.2870
-0.0189-6.18%
近くで: Nov 20, 4:00 PM EST
$0.2798
-0.0072-2.51%
時間外: 7:43 PM EST

The average analyst price target for Tempest Therapeutics is $27, 9549.7% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $7 to $65. The latest change came on Sep 24, 2026, when HC Wainwright & Co. lowered its price target on Tempest Therapeutics from $11 to $7 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months